Hepatology

Protocol for a prospective double-blind, randomised, placebo-controlled feasibility trial of octreotide infusion during liver transplantation
Jeremy Fabes, Gareth Ambler, Bina Shah, Norman R Williams, Daniel Martin, Brian R Davidson, Michael Spiro

BMJ Open Dec 2021, 11 (12) e055864; DOI: 10.1136/bmjopen-2021-055864
Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD)? protocol for a feasibility randomised controlled trial
Mohsan Subhani, Katy A Jones, Kirsty Sprange, Stefan Rennick-Egglestone, Holly Knight, Joanne R Morling, Doyo G Enki, Andrew Wragg, Stephen D Ryder

BMJ Open Nov 2021, 11 (11) e054954; DOI: 10.1136/bmjopen-2021-054954
Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol
Shu Zhu, Lina Wu, Yongyu Mei, Zhihua Liu, Luping Lin, Jing Yuan, Jianguo Li, Xuejun Li, Liang Peng

BMJ Open Oct 2021, 11 (10) e049104; DOI: 10.1136/bmjopen-2021-049104
Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care
Jeffrey V Lazarus, Andrea Herranz, Camila A Picchio, Marcela Villota-Rivas, Antonia Rodríguez, Juan Manuel Alonso, Albert Moratinos, Antonella Perrotta, Elisabet Tegeo, Francisca Bibiloni, Maria Buti, Àngels Vilella

BMJ Open Oct 2021, 11 (10) e053394; DOI: 10.1136/bmjopen-2021-053394
Association between self-monitoring of blood glucose and hepatitis B virus infection among people with diabetes mellitus: a cross-sectional study in Gansu Province, China
Bingfeng Han, Wu Liu, Shubo Yang, Shuai Wang, Juan Du, Yaqiong Liu, Fuqiang Cui

BMJ Open Oct 2021, 11 (10) e048463; DOI: 10.1136/bmjopen-2020-048463
Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation
Amina Al-Awadi, Jane Grove, Moira Taylor, Ana Valdes, Amrita Vijay, Stephen Bawden, Penny Gowland, Guruprasad Aithal

BMJ Open Oct 2021, 11 (10) e045802; DOI: 10.1136/bmjopen-2020-045802
Risk of aortic dissection or aneurysm in patients with gallstone disease: a retrospective cohort study in Taiwan
Chien-Hua Chen, Cheng-Li Lin, Chia-Hung Kao

BMJ Open Aug 2021, 11 (8) e049316; DOI: 10.1136/bmjopen-2021-049316
Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial
Lu Wang, Lina Wu, Xuejun Li, Ying Zhang, Jing Lai, Xiang Zhu, Chan Xie, Liang Peng

BMJ Open Aug 2021, 11 (8) e048410; DOI: 10.1136/bmjopen-2020-048410
What to measure in biliary atresia research: study protocol for developing a core outcome set
Christopher Maguire, Zephanie Tyack, Roy M Kimble, Bronwyn Ruth Griffin, Helen Joanna Yesberg, Fang Ming Choo, Craig Antony McBride

BMJ Open Aug 2021, 11 (8) e047224; DOI: 10.1136/bmjopen-2020-047224
Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis
Tharusan Thevathasan, Teresa Colbatzky, Moritz Schmelzle, Johann Pratschke, Felix Krenzien

BMJ Open Aug 2021, 11 (8) e045733; DOI: 10.1136/bmjopen-2020-045733

Main menu

Hepatology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hepatology

Pages